Christopher Pierce
No más puestos en curso
Perfil
Christopher Pierce worked as Senior Director-Hematologic Malignancies Portfolio at Pfizer Inc. from 2016 to 2017.
He then worked as Vice President & Head-Commercial at Loxo Oncology, Inc. from 2017 to 2019.
In 2019, he worked as Principal at Scout Advisers LLC.
In 2020, he worked as Chief Business Operations & Executive VP at Prelude Therapeutics, Inc. Mr. Pierce holds an MBA from Harvard Business School and an undergraduate degree from Harvard College.
Antiguos cargos conocidos de Christopher Pierce.
| Empresas | Cargo | Fin |
|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Corporate Officer/Principal | 30/09/2021 |
| Scout Advisers LLC | Corporate Officer/Principal | 01/07/2020 |
| LOXO ONCOLOGY INC | Corporate Officer/Principal | 01/05/2019 |
| PFIZER, INC. | Corporate Officer/Principal | 01/03/2017 |
Formación de Christopher Pierce.
| Harvard College | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
| PFIZER, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
| Scout Advisers LLC | |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |
- Bolsa de valores
- Insiders
- Christopher Pierce
